National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

autologous Epstein-Barr virus-specific cytotoxic T lymphocytes
A preparation of lymphocytes harvested from a patient with an Epstein-Barr virus (EBV)-positive tumor. Ex vivo, the lymphocytes are activated against EBV-specific antigens and then returned to the patient, where they mount a specific immune response against EBV-positive tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:EBV-specific CTL
Abbreviation:EBV CTL



Previous:autologous dendritic cell-autologous tumor mRNA-human CD40L vaccine, autologous dendritic cell-tumor fusion vaccine, autologous dinitrophenyl-modified ovarian cancer vaccine, autologous EBV-CTL CD19CAR zeta, autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine
Next:autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine, autologous expanded mesenchymal stem cells OTI-010, autologous heat-shock protein 70 peptide vaccine AG-858, autologous immunoglobulin idiotype-KLH conjugate vaccine, autologous LMP1-/LMP2- specific cytotoxic T-lymphocytes

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov